Advertisement
YOU ARE HERE: LAT HomeCollectionsDrug
IN THE NEWS

Drug

NATIONAL
May 23, 2013 | By Richard A. Serrano
WASHINGTON - A top Mexican drug cartel commander pleaded guilty Thursday in U.S. District Court  in the 2011 ambush attack south of the border that left one American agent dead and a second injured, and three other defendants also admitted their roles in the shootings that sharply strained U.S.-Mexico relations and has prosecutors still hunting for more suspects. The developments in federal court in Washington also provided new details about the ambush, showing that U.S. Immigration and Customs Enforcement special agents Jaime Zapata and Victor Avila were traveling near San Luis Potosi, Mexico, when a Los Zetas Cartel convoy forced them off the road and two “armed hit squads” surrounded their vehicle and demanded they step out. When the agents refused and identified themselves as American diplomats from the U.S.  Embassy, the assailants “fired weapons near and into the vehicle, striking both agents,” court records show.
Advertisement
CALIFORNIA | LOCAL
February 27, 2014 | By Paloma Esquivel
An alleged drug supplier went on trial in Orange County on Thursday  on charges that he killed a man he believed had stolen drugs from his dealers. Jose Felix Zepeda, 41, is charged with felony special circumstances murder during the commission of a robbery, felony kidnapping and felony conspiracy to commit a crime. If convicted, he faces a maximum sentence of life in state prison without parole. Zepeda has pleaded not guilty to all charges. Prosecutors say that in April 2012, Zepeda supplied three pounds of methamphetamine to two men who were supposed to sell the drugs to a buyer.
NEWS
March 11, 2013 | By Melissa Healy
In patients with moderate Alzheimer's disease, an experimental drug that alters the brain's "fight or flight" impulse succeeded in improving memory modestly when it was added to at least one of the medications already in wide use to treat the memory-robbing disease. Compared with subjects taking the drug memantine and a placebo, subjects supplementing their customary drug regimen for three months with the experimental drug--ORM-12741--scored more highly on two measures of memory.
BUSINESS
March 5, 2013 | By Shan Li
Mexican drug kingpin Joaquin "Chapo" Guzman has fallen off Forbes magazine's annual list of the world's billionaires. Guzman, who has been in hiding since escaping from a maximum-security prison in 2001, is chieftain of the Sinaloa cartel, Mexico's biggest and oldest drug-trafficking network. He first made the billionaire list in 2009 and remained on it until this year. Luisa Kroll, an editor at Forbes, said that Guzman's "whereabouts are unknown" and therefore it's difficult to verify his assets.
WORLD
January 8, 2009 | Reuters
Mexico has captured one of the founders of the Gulf drug cartel's brutal "Zetas" squad of hitmen that is behind much of the country's bloodshed, the attorney general's office said Thursday. Miguel Angel Soto Parra, arrested Wednesday in Mexico City, is a former police officer who was one of the earliest members of the Zetas, a group of hitmen made up largely of army deserters, a source at the attorney general's office said. President Felipe Calderon has scored a number of big arrests since he sent the army to crack down on drug gangs.
CALIFORNIA | LOCAL
September 26, 2013 | By Angel Jennings
Eight men with ties to a Mexican drug ring were arrested after authorities in the Central Valley discovered a drug den filled with more than $1 million in processed marijuana, authorities said. A narcotics team served a search warrant to residents inside the Madera home Wednesday after receiving a tip of a "menacing grow," said Erica Stuart, spokeswoman for the Madera County Sheriff's Office.  Agents seized 83 plants, 500 pounds of processed marijuana and another 30 pounds of packaged marijuana "ready to hit the streets," she said.
NEWS
February 20, 2012 | By Melissa Healy, Los Angeles Times/For the Booster Shots Blog
Could freestyle skier Sarah Burke, who died Jan. 19, nine days after a devastating crash, have been helped by an experimental drug? A new study offers a glimmer of hope for future victims of traumatic brain injury. In the hours after she has sustained a blow to the head, the victim of a traumatic injury experiences a slow down of blood flow to the brain--arguably when she needs it most. That mismatch between a brain's response and its needs in the wake of injury has set many a neuroscientist thinking: Can a way be found to keep the flow of oxygenated blood pumping normally?
CALIFORNIA | LOCAL
December 28, 2013 | By Tony Perry
SAN DIEGO - An American citizen died while in custody of the U.S. Border Patrol after being arrested on suspicion of possession of marijuana, authorities said. The death occurred early on Christmas Day at the Border Patrol's Campo Station in southern San Diego County. The name and age of the dead man were not released. The Border Patrol said that the man "became incoherent and unresponsive" while in a holding cell after being arrested early Tuesday evening. After midnight, paramedics attempted CPR but were unable to revive the man, the Border Patrol said.
NATIONAL
January 2, 2014 | By Matt Pearce
This just might be a case of life imitating art: On Thursday, Florida officials announced that they arrested a "Breaking Bad" contest winner on suspicion of helping run a nationwide drug ring out of his home. However, instead of making meth, like the chemistry teacher in the popular show, Ryan Lee Carroll and two other men converted their apartment's garage into an elaborate lab for making synthetic marijuana, likely for large-scale distribution, according to the Lee County Sheriff's Office.
BUSINESS
January 23, 2013 | Bloomberg News
Allergan Inc., the Irvine maker of the wrinkle filler Botox, agreed to buy a Silicon Valley pharmaceutical company in a deal valued at $958 million to gain an experimental inhalable migraine treatment. Allergan will pay Map Pharmaceuticals Inc. investors $25 a share, a 60% premium over Tuesday's closing price of $15.58 in New York, the companies said in a statement. The deal was unanimously approved by the boards of both companies and is expected to close late in the first quarter or in the second quarter, the companies said.
Los Angeles Times Articles
|